BEBT 809
Alternative Names: BEBT-809Latest Information Update: 03 Apr 2023
At a glance
- Originator BeBetter Med
- Class Obesity therapies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity